FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129442050> ?p ?o ?g. }

• W2129442050 endingPage "8" @default.
• W2129442050 startingPage "1973" @default.
• W2129442050 abstract "Nucleolar antigen P120 is detected in rapidly proliferating cells but not in normal resting cells or in many benign and slowly growing malignant tumors. The objective of the study was to determine whether the expression of P120 in breast cancer correlated with histopathological or biological properties associated with prognosis. In this retrospective study, 120 primary breast tumors were analyzed for P120; 114 of these tumors were also stained for the erbB-2 protein. Immunopositive staining was correlated with patient survival, nodal status, estrogen receptor levels, and number of mitoses. Sixty-nine % (83 of 120) of the tumors were positive for P120; 25% (28 of 114) stained positively for erbB-2. Of the 28 erbB-2 positive tumors 26 were also positive for the P120 protein. Forty-six % (55 of 120) of the specimens were from patients who later died from recurrent breast cancer; P120 was detected in 89% (49 of 55) of these specimens. In 52% of the survivors the P120 protein was also expressed. P120 negative tumors were highly correlative with survival (P = 0.0001); 84% (32 of 37) of patients with P120 negative tumors survived more than 7 years without evidence of recurrent disease. Multivariate analysis showed that the worst prognosis was for patients who had tumor positive nodes and expressed P120 (P = 0.0001); death occurred in 73% (30 of 41) of these patients. For the node negative patients who did not express P120, 5-year survival was 90% (19 of 21 patients); 5-year survival for the node negative patients who expressed P120 was significantly less (67%; 28 of 42 patients). Patients with P120 negative tumors had a good prognosis, irrespective of their nodal status. In this group, survival of node negative patients was 86% (18 of 21) and for those with positive nodes survival was 82% (13 of 16). A poor prognosis was found for patients with intense erbB-2 stained tumors (5 of 7 patients died). Weak staining of erbB-2 tumors (21 specimens) was not correlated with patient survival. Compared to P120 negative tumors, P120 positive tumors had greater numbers of mitoses (9.06 versus 6.65) and an almost 2-fold increase in the occurrence of positive nodes (one of every 4.67 versus one of every 8.81). The number of P120 positive tumors was greater in estrogen receptor positive tumors (75%) than in estrogen negative tumors (54%).(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
• W2129442050 created "2016-06-24" @default.
• W2129442050 creator A5018068784 @default.
• W2129442050 creator A5033461633 @default.
• W2129442050 creator A5038334502 @default.
• W2129442050 creator A5072701925 @default.
• W2129442050 creator A5073393035 @default.
• W2129442050 creator A5075257231 @default.
• W2129442050 creator A5075279247 @default.
• W2129442050 creator A5087216176 @default.
• W2129442050 date "1991-04-15" @default.
• W2129442050 modified "2023-10-03" @default.
• W2129442050 title "Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma." @default.
• W2129442050 cites W1519437906 @default.
• W2129442050 cites W1580788756 @default.
• W2129442050 cites W1878878318 @default.
• W2129442050 cites W1979300931 @default.
• W2129442050 cites W1981071486 @default.
• W2129442050 cites W2004585781 @default.
• W2129442050 cites W2008251456 @default.
• W2129442050 cites W2020367356 @default.
• W2129442050 cites W2040294102 @default.
• W2129442050 cites W2079655977 @default.
• W2129442050 cites W2082450966 @default.
• W2129442050 cites W2111502456 @default.
• W2129442050 cites W2131149847 @default.
• W2129442050 cites W2141393790 @default.
• W2129442050 cites W2165528796 @default.
• W2129442050 cites W2220500259 @default.
• W2129442050 cites W2230285032 @default.
• W2129442050 cites W2322326756 @default.
• W2129442050 cites W2326165980 @default.
• W2129442050 cites W2328982008 @default.
• W2129442050 cites W2341230536 @default.
• W2129442050 cites W2402935659 @default.
• W2129442050 cites W2417418130 @default.
• W2129442050 cites W2421391716 @default.
• W2129442050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1672621" @default.
• W2129442050 hasPublicationYear "1991" @default.
• W2129442050 type Work @default.
• W2129442050 sameAs 2129442050 @default.
• W2129442050 citedByCount "26" @default.
• W2129442050 countsByYear W21294420502015 @default.
• W2129442050 countsByYear W21294420502021 @default.
• W2129442050 countsByYear W21294420502022 @default.
• W2129442050 countsByYear W21294420502023 @default.
• W2129442050 crossrefType "journal-article" @default.
• W2129442050 hasAuthorship W2129442050A5018068784 @default.
• W2129442050 hasAuthorship W2129442050A5033461633 @default.
• W2129442050 hasAuthorship W2129442050A5038334502 @default.
• W2129442050 hasAuthorship W2129442050A5072701925 @default.
• W2129442050 hasAuthorship W2129442050A5073393035 @default.
• W2129442050 hasAuthorship W2129442050A5075257231 @default.
• W2129442050 hasAuthorship W2129442050A5075279247 @default.
• W2129442050 hasAuthorship W2129442050A5087216176 @default.
• W2129442050 hasConcept C121608353 @default.
• W2129442050 hasConcept C126322002 @default.
• W2129442050 hasConcept C142724271 @default.
• W2129442050 hasConcept C143998085 @default.
• W2129442050 hasConcept C146357865 @default.
• W2129442050 hasConcept C147483822 @default.
• W2129442050 hasConcept C151730666 @default.
• W2129442050 hasConcept C203014093 @default.
• W2129442050 hasConcept C204232928 @default.
• W2129442050 hasConcept C2777546739 @default.
• W2129442050 hasConcept C2778001805 @default.
• W2129442050 hasConcept C3018521938 @default.
• W2129442050 hasConcept C530470458 @default.
• W2129442050 hasConcept C71924100 @default.
• W2129442050 hasConcept C84606932 @default.
• W2129442050 hasConcept C86803240 @default.
• W2129442050 hasConceptScore W2129442050C121608353 @default.
• W2129442050 hasConceptScore W2129442050C126322002 @default.
• W2129442050 hasConceptScore W2129442050C142724271 @default.
• W2129442050 hasConceptScore W2129442050C143998085 @default.
• W2129442050 hasConceptScore W2129442050C146357865 @default.
• W2129442050 hasConceptScore W2129442050C147483822 @default.
• W2129442050 hasConceptScore W2129442050C151730666 @default.
• W2129442050 hasConceptScore W2129442050C203014093 @default.
• W2129442050 hasConceptScore W2129442050C204232928 @default.
• W2129442050 hasConceptScore W2129442050C2777546739 @default.
• W2129442050 hasConceptScore W2129442050C2778001805 @default.
• W2129442050 hasConceptScore W2129442050C3018521938 @default.
• W2129442050 hasConceptScore W2129442050C530470458 @default.
• W2129442050 hasConceptScore W2129442050C71924100 @default.
• W2129442050 hasConceptScore W2129442050C84606932 @default.
• W2129442050 hasConceptScore W2129442050C86803240 @default.
• W2129442050 hasIssue "8" @default.
• W2129442050 hasLocation W21294420501 @default.
• W2129442050 hasOpenAccess W2129442050 @default.
• W2129442050 hasPrimaryLocation W21294420501 @default.
• W2129442050 hasRelatedWork W2016652641 @default.
• W2129442050 hasRelatedWork W2044147539 @default.
• W2129442050 hasRelatedWork W2076602177 @default.
• W2129442050 hasRelatedWork W2079812925 @default.
• W2129442050 hasRelatedWork W2159711144 @default.
• W2129442050 hasRelatedWork W2468480624 @default.
• W2129442050 hasRelatedWork W2472902296 @default.

• next